Scarica l'app Stockscreener
88.42
1.43%
1.245
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$87.17
Aprire:
$86.83
Volume 24 ore:
4.65M
Relative Volume:
0.61
Capitalizzazione di mercato:
$112.76B
Reddito:
$33.54B
Utile/perdita netta:
$4.66B
Rapporto P/E:
24.42
EPS:
3.62
Flusso di cassa netto:
$5.19B
1 W Prestazione:
+2.72%
1M Prestazione:
+6.56%
6M Prestazione:
+10.69%
1 anno Prestazione:
+14.65%
Intervallo 1D:
$86.71
$88.65
Intervallo di 1 settimana:
$85.22
$88.65
Portata 52W:
$75.96
$96.25
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
88.41 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
ABT
Abbott Laboratories
|
136.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.89 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.95 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
EW
Edwards Lifesciences Corp
|
77.22 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Medtronic Diabetes and tennis pro Alexander Zverev join forces to champion life without limits for people with diabetes - Medtronic
Medtronic training pact includes Hugo robot, cardiac ablation tech - MedTech Dive
Medtronic stock has significant opportunity in renal denervation, RBC says By Investing.com - Investing.com UK
FDA Clears Minimally Invasive Laser Ablation System from Medtronic for Epilepsy & Brain Tumors - Medical Device and Diagnostic industry
Medtronic partners with IRCAD on Hugo, Affera surgical training - MassDevice
Medtronic to invest $50 million over five years in Pune GCC - BusinessLine
Medtronic : IRCAD North America and Medtronic announce collaboration to advance surgical training and innovation - MarketScreener
Surgical Retractors Market Top Companies StudyMedtronic Plc, - openPR.com
Medtronic to invest $50 million over 5 years in Pune - PUNE PULSE
Medtronic plc Stock MDT Using Cash Flow Model NYSE Composite - Kalkine Media
A Look At The Fair Value Of Medtronic plc (NYSE:MDT) - simplywall.st
Medtronic to invest $50 million over 5 years in New Diabetes Global Capability Centre in Pune - Punekar News
Medtronic Invests $50M in Pune Diabetes Center - Rediff MoneyWiz
Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings - Investing.com Nigeria
Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings By Investing.com - Investing.com South Africa
Leerink Partners Initiates Coverage on Medtronic (MDT) with Outperform Rating | MDT Stock News - GuruFocus
Medtronic (MDT) Positioned for Growth Amid Strategic Shifts | MDT Stock News - GuruFocus
Leerink Partners Initiates Medtronic at Outperform With $110 Price Target - MarketScreener
Medtronic: Solid Recent Performance But Better Options Available (NYSE:MDT) - Seeking Alpha
Medtronic Doubles Down on Innovation as Cardiovascular Tech Takes Center Stage! - Smartkarma
Medtronic’s SWOT analysis: stock outlook amid diabetes spin-off and RDN growth - Investing.com
Medtronic separate diabetes business to be called MiniMed - MSN
Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst - Benzinga
FDA approves Medtronic Omniasecure defib lead - BioWorld MedTech
Medtronic Plc. (NYSE: MDT) To Separate Its Diabetes Business - Smartkarma
Earnings Preview: What To Expect From Medtronic’s Report - MSN
Medtronic Diabetes Spinoff to Honor MiniMed Roots - Medical Device and Diagnostic industry
Medtronic (MDT) Revives MiniMed for Diabetes Spin-Off - GuruFocus
Medtronic recalls ventilators linked to 2 serious injuries, 1 death - MedTech Dive
Medtronic issues safety notice for Hugo surgical robot console in Europe - MassDevice
Medtronic announces MiniMed as name for planned New Diabetes Company - GuruFocus
Medtronic (MDT) Unveils "MiniMed" for Upcoming Diabetes Spinoff - GuruFocus
Medtronic's New Diabetes Company to Be Named MiniMed - MarketScreener
Medtronic announces MiniMed as name for planned New Diabetes Company | MDT Stock News - GuruFocus
Medtronic names planned diabetes spinoff company MiniMed - Investing.com
Medtronic names planned diabetes spinoff company MiniMed By Investing.com - Investing.com Canada
Medtronic Announces MiniMed As Name For Planned New Diabetes Company - marketscreener.com
FDA Upgrades Medtronic Recall Of Newport Ventilators To Class I - RTTNews
Medtronic Q4 Earnings and Revenues Top, Stock Down in Pre-market - MSN
Medtronic advises discontinuation of certain Newport ventilators after recall - MassDevice
Medtronic : announces voluntary recall of select Newport™ HT70 and Newport™ HT70 Plus ventilators and certain related Newport™ service parts - marketscreener.com
Medtronic : treats first U.S. patient in Global SYMPLICITY Registry DEFINE Study - marketscreener.com
5 Things You Need to Know If You Buy Medtronic Today - The Motley Fool
Medtronic names Kate Benedict president of acute care and monitoring - MedTech Dive
Medtronic appoints new president of Acute Care & Monitoring unit - MassDevice
Medtronic Announces Intent To Spin Diabetes Business - Forbes
Medtronic wins CE mark for VitalFlow ECMO system - MassDevice
Medtronic to separate diabetes business, WSJ reports - MSN
Medtronic's Separation of Diabetes Business May Drive Long-Term Value, Needham Says - marketscreener.com
Medtronic removes tracheostomy tubes due to dislodging risk - MedTech Dive
NEEDHAM ANALYST MAINTAINS HOLD RATING ON MEDTRONIC STOCK By Investing.com - Investing.com UK
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Medtronic Plc Azioni (MDT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Walter Matthew R. | SVP, Chief HR Officer |
Jan 27 '25 |
Option Exercise |
74.84 |
1,337 |
100,061 |
26,997 |
| Marinaro Michael | EVP & President, Surgical OU |
Jan 27 '25 |
Option Exercise |
74.84 |
2,345 |
175,500 |
43,323 |
| Martha Geoffrey | Chairman and CEO |
Jan 27 '25 |
Option Exercise |
74.84 |
34,741 |
2,600,016 |
216,954 |
| Wall Brett A. | EVP & Pres Neuroscience |
Jan 24 '25 |
Option Exercise |
78.00 |
12,437 |
970,086 |
53,416 |
| Wall Brett A. | EVP & Pres Neuroscience |
Jan 24 '25 |
Sale |
90.00 |
12,437 |
1,119,330 |
40,979 |
0.36%
2.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):